サマリー

市場分析と洞察。整形外科用細胞治療の世界市場
整形外科細胞治療の世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間に年平均成長率（%）で推移しています。
この健康危機による経済変化を十分に考慮し、2021年に整形外科細胞療法世界市場の％を占めた血小板豊富血漿注入は、2022年から2028年まで改訂された％のCAGRで成長し、2028年までに100万米ドルを値にすると予測されます。一方、骨折のセグメントは、この予測期間を通じて、CAGRに変更されています。

中国の整形外科細胞治療の市場規模は2021年に百万米ドル、北米と欧州の整形外科細胞治療はそれぞれ百万米ドルと百万米ドルです。北米の割合は2021年に％、中国と欧州はそれぞれ％、％であり、中国の割合は2028年に％に達すると予測され、分析期間2022-2028年を通じてCAGRは％であることがわかりました。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％である。欧州の整形外科細胞治療の展望については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間2022-2028年を通じてCAGR %で推移しています。

本レポートは、業界標準の分析精度と高いデータ整合性により、整形外科細胞治療の世界市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得できるよう支援する素晴らしい試みを行っています。本レポートの購入者は、整形外科細胞治療の世界市場規模（売上高）など、検証済みで信頼できる市場予測にアクセスすることができます。
全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の整形外科細胞治療市場で持続的な成功を収めるために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されています。本レポートを執筆したアナリストは、世界の整形外科細胞療法市場を詳細に調査するため、独自の業界最高水準の調査・分析アプローチを採用しています。

整形外科細胞治療の世界市場範囲と市場規模
整形外科細胞治療の市場は、プレイヤー、地域（国）、タイプ、用途別に分類されます。整形外科細胞治療の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てます。

タイプ別セグメント
血小板を多く含む血漿注入
骨髄療法（Bone Marrow Therapy
その他

用途別セグメント
骨折
軟部組織挫傷
変形性関節症
その他

会社別
メドトロニック
ジェンザイム
デピューシンセス
アニカ セラピューティック
フェリング・ファーマシューティカルズ
ストライカー
ニューベーシブ
バイオベンタス
ジンマー・バイオメット
インテグラライフサイエンス
RTIサージカル
フィディア・ファーマシューティカルズ
MTF
オルソフィックス
アーストレックス

地域別
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
その他のヨーロッパ
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
中南米
メキシコ
ブラジル
ラテンアメリカの残りの部分
中近東・アフリカ
トルコ
サウジアラビア
UAE
MEAの残りの地域

ページTOPに戻る

目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orthopedic Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Platelet-rich Plasma Injection
1.2.3 Bone Marrow Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Orthopedic Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Fractures
1.3.3 Soft Tissue Contusions
1.3.4 Osteoarthritis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Orthopedic Cell Therapy Market Perspective (2017-2028)
2.2 Orthopedic Cell Therapy Growth Trends by Region
2.2.1 Orthopedic Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Orthopedic Cell Therapy Historic Market Size by Region (2017-2022)
2.2.3 Orthopedic Cell Therapy Forecasted Market Size by Region (2023-2028)
2.3 Orthopedic Cell Therapy Market Dynamics
2.3.1 Orthopedic Cell Therapy Industry Trends
2.3.2 Orthopedic Cell Therapy Market Drivers
2.3.3 Orthopedic Cell Therapy Market Challenges
2.3.4 Orthopedic Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Orthopedic Cell Therapy Players by Revenue
3.1.1 Global Top Orthopedic Cell Therapy Players by Revenue (2017-2022)
3.1.2 Global Orthopedic Cell Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Orthopedic Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Orthopedic Cell Therapy Revenue
3.4 Global Orthopedic Cell Therapy Market Concentration Ratio
3.4.1 Global Orthopedic Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orthopedic Cell Therapy Revenue in 2021
3.5 Orthopedic Cell Therapy Key Players Head office and Area Served
3.6 Key Players Orthopedic Cell Therapy Product Solution and Service
3.7 Date of Enter into Orthopedic Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Orthopedic Cell Therapy Breakdown Data by Type
4.1 Global Orthopedic Cell Therapy Historic Market Size by Type (2017-2022)
4.2 Global Orthopedic Cell Therapy Forecasted Market Size by Type (2023-2028)
5 Orthopedic Cell Therapy Breakdown Data by Application
5.1 Global Orthopedic Cell Therapy Historic Market Size by Application (2017-2022)
5.2 Global Orthopedic Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Orthopedic Cell Therapy Market Size (2017-2028)
6.2 North America Orthopedic Cell Therapy Market Size by Type
6.2.1 North America Orthopedic Cell Therapy Market Size by Type (2017-2022)
6.2.2 North America Orthopedic Cell Therapy Market Size by Type (2023-2028)
6.2.3 North America Orthopedic Cell Therapy Market Share by Type (2017-2028)
6.3 North America Orthopedic Cell Therapy Market Size by Application
6.3.1 North America Orthopedic Cell Therapy Market Size by Application (2017-2022)
6.3.2 North America Orthopedic Cell Therapy Market Size by Application (2023-2028)
6.3.3 North America Orthopedic Cell Therapy Market Share by Application (2017-2028)
6.4 North America Orthopedic Cell Therapy Market Size by Country
6.4.1 North America Orthopedic Cell Therapy Market Size by Country (2017-2022)
6.4.2 North America Orthopedic Cell Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Orthopedic Cell Therapy Market Size (2017-2028)
7.2 Europe Orthopedic Cell Therapy Market Size by Type
7.2.1 Europe Orthopedic Cell Therapy Market Size by Type (2017-2022)
7.2.2 Europe Orthopedic Cell Therapy Market Size by Type (2023-2028)
7.2.3 Europe Orthopedic Cell Therapy Market Share by Type (2017-2028)
7.3 Europe Orthopedic Cell Therapy Market Size by Application
7.3.1 Europe Orthopedic Cell Therapy Market Size by Application (2017-2022)
7.3.2 Europe Orthopedic Cell Therapy Market Size by Application (2023-2028)
7.3.3 Europe Orthopedic Cell Therapy Market Share by Application (2017-2028)
7.4 Europe Orthopedic Cell Therapy Market Size by Country
7.4.1 Europe Orthopedic Cell Therapy Market Size by Country (2017-2022)
7.4.2 Europe Orthopedic Cell Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Orthopedic Cell Therapy Market Size (2017-2028)
8.2 Asia-Pacific Orthopedic Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Orthopedic Cell Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Orthopedic Cell Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Orthopedic Cell Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Orthopedic Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Orthopedic Cell Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Orthopedic Cell Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Orthopedic Cell Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Orthopedic Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Orthopedic Cell Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Orthopedic Cell Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Orthopedic Cell Therapy Market Size (2017-2028)
9.2 Latin America Orthopedic Cell Therapy Market Size by Type
9.2.1 Latin America Orthopedic Cell Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Orthopedic Cell Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Orthopedic Cell Therapy Market Share by Type (2017-2028)
9.3 Latin America Orthopedic Cell Therapy Market Size by Application
9.3.1 Latin America Orthopedic Cell Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Orthopedic Cell Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Orthopedic Cell Therapy Market Share by Application (2017-2028)
9.4 Latin America Orthopedic Cell Therapy Market Size by Country
9.4.1 Latin America Orthopedic Cell Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Orthopedic Cell Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Orthopedic Cell Therapy Market Size (2017-2028)
10.2 Middle East & Africa Orthopedic Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Orthopedic Cell Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Orthopedic Cell Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Orthopedic Cell Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Orthopedic Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Orthopedic Cell Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Orthopedic Cell Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Orthopedic Cell Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Orthopedic Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Orthopedic Cell Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Orthopedic Cell Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Orthopedic Cell Therapy Introduction
11.1.4 Medtronic Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.1.5 Medtronic Recent Developments
11.2 Genzyme
11.2.1 Genzyme Company Details
11.2.2 Genzyme Business Overview
11.2.3 Genzyme Orthopedic Cell Therapy Introduction
11.2.4 Genzyme Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.2.5 Genzyme Recent Developments
11.3 DePuy Synthes
11.3.1 DePuy Synthes Company Details
11.3.2 DePuy Synthes Business Overview
11.3.3 DePuy Synthes Orthopedic Cell Therapy Introduction
11.3.4 DePuy Synthes Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.3.5 DePuy Synthes Recent Developments
11.4 Anika Therapeutics
11.4.1 Anika Therapeutics Company Details
11.4.2 Anika Therapeutics Business Overview
11.4.3 Anika Therapeutics Orthopedic Cell Therapy Introduction
11.4.4 Anika Therapeutics Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.4.5 Anika Therapeutics Recent Developments
11.5 Ferring Pharmaceuticals
11.5.1 Ferring Pharmaceuticals Company Details
11.5.2 Ferring Pharmaceuticals Business Overview
11.5.3 Ferring Pharmaceuticals Orthopedic Cell Therapy Introduction
11.5.4 Ferring Pharmaceuticals Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.5.5 Ferring Pharmaceuticals Recent Developments
11.6 Stryker
11.6.1 Stryker Company Details
11.6.2 Stryker Business Overview
11.6.3 Stryker Orthopedic Cell Therapy Introduction
11.6.4 Stryker Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.6.5 Stryker Recent Developments
11.7 NuVasive
11.7.1 NuVasive Company Details
11.7.2 NuVasive Business Overview
11.7.3 NuVasive Orthopedic Cell Therapy Introduction
11.7.4 NuVasive Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.7.5 NuVasive Recent Developments
11.8 Bioventus
11.8.1 Bioventus Company Details
11.8.2 Bioventus Business Overview
11.8.3 Bioventus Orthopedic Cell Therapy Introduction
11.8.4 Bioventus Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.8.5 Bioventus Recent Developments
11.9 Zimmer Biomet
11.9.1 Zimmer Biomet Company Details
11.9.2 Zimmer Biomet Business Overview
11.9.3 Zimmer Biomet Orthopedic Cell Therapy Introduction
11.9.4 Zimmer Biomet Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.9.5 Zimmer Biomet Recent Developments
11.10 Integra LifeSciences
11.10.1 Integra LifeSciences Company Details
11.10.2 Integra LifeSciences Business Overview
11.10.3 Integra LifeSciences Orthopedic Cell Therapy Introduction
11.10.4 Integra LifeSciences Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.10.5 Integra LifeSciences Recent Developments
11.11 RTI Surgical
11.11.1 RTI Surgical Company Details
11.11.2 RTI Surgical Business Overview
11.11.3 RTI Surgical Orthopedic Cell Therapy Introduction
11.11.4 RTI Surgical Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.11.5 RTI Surgical Recent Developments
11.12 Fidia Pharmaceuticals
11.12.1 Fidia Pharmaceuticals Company Details
11.12.2 Fidia Pharmaceuticals Business Overview
11.12.3 Fidia Pharmaceuticals Orthopedic Cell Therapy Introduction
11.12.4 Fidia Pharmaceuticals Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.12.5 Fidia Pharmaceuticals Recent Developments
11.13 MTF
11.13.1 MTF Company Details
11.13.2 MTF Business Overview
11.13.3 MTF Orthopedic Cell Therapy Introduction
11.13.4 MTF Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.13.5 MTF Recent Developments
11.14 Orthofix
11.14.1 Orthofix Company Details
11.14.2 Orthofix Business Overview
11.14.3 Orthofix Orthopedic Cell Therapy Introduction
11.14.4 Orthofix Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.14.5 Orthofix Recent Developments
11.15 Arthrex
11.15.1 Arthrex Company Details
11.15.2 Arthrex Business Overview
11.15.3 Arthrex Orthopedic Cell Therapy Introduction
11.15.4 Arthrex Revenue in Orthopedic Cell Therapy Business (2017-2022)
11.15.5 Arthrex Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer